{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:16:56Z","timestamp":1793146616603,"version":"4.5.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T00:00:00Z","timestamp":1549584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12035-019-1500-y","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T20:02:42Z","timestamp":1549569762000},"page":"6156-6167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":323,"title":["Systematic Review of miRNA as Biomarkers in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"56","author":[{"given":"S.","family":"Swarbrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Wragg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2975-5736","authenticated-orcid":false,"given":"Alexandra","family":"Stolzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,8]]},"reference":[{"issue":"7","key":"1500_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34(7):939\u2013944","journal-title":"Neurology"},{"key":"1500_CR2","volume-title":"Dementia 2014 opportunity for change report","author":"AS Anna Dowrick","year":"2014","unstructured":"Anna Dowrick AS (2014) Dementia 2014 opportunity for change report. A.s. Society, Editor"},{"key":"1500_CR3","unstructured":"Team, O.P.a.D., Prime minister\u2019s challenge on dementia, D.o. Health, Editor. 2012."},{"issue":"4","key":"1500_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/WAD.0b013e3181a6bebc","volume":"23","author":"A Bradford","year":"2009","unstructured":"Bradford A, Kunik ME, Schulz P, Williams SP, Singh H (2009) Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord 23(4):306\u2013314","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"1500_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0306-4522(95)90397-P","volume":"64","author":"TG Ohm","year":"1995","unstructured":"Ohm TG, M\u00fcller H, Braak H, Bohl J (1995) Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer\u2019s disease-related neurofibrillary changes. Neuroscience 64(1):209\u2013217","journal-title":"Neuroscience"},{"issue":"4","key":"1500_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239\u2013259","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1500_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G","volume":"8","author":"E Tulving","year":"1998","unstructured":"Tulving E, Markowitsch HJ (1998) Episodic and declarative memory: role of the hippocampus. Hippocampus 8(3):198\u2013204","journal-title":"Hippocampus"},{"issue":"1","key":"1500_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejphar.2006.06.023","volume":"545","author":"B Borroni","year":"2006","unstructured":"Borroni B, Di Luca M, Padovani A (2006) Predicting Alzheimer dementia in mild cognitive impairment patients. Are biomarkers useful? Eur J Pharmacol 545(1):73\u201380","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"1500_CR9","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","volume":"56","author":"DS Knopman","year":"2001","unstructured":"Knopman DS et al (2001) Practice parameter: diagnosis of dementia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 56(9):1143\u20131153","journal-title":"Neurology"},{"issue":"9","key":"1500_CR10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","volume":"40","author":"TN Tombaugh","year":"1992","unstructured":"Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40(9):922\u2013935","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1500_CR11","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1212\/WNL.52.6.1158","volume":"52","author":"A Delacourte","year":"1999","unstructured":"Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C et al (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer\u2019s disease. Neurology 52(6):1158\u20131165","journal-title":"Neurology"},{"issue":"7","key":"1500_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/gps.4053","volume":"29","author":"T Wang","year":"2014","unstructured":"Wang T, Xiao S, Liu Y, Lin Z, Su N, Li X, Li G, Zhang M et al (2014) The efficacy of plasma biomarkers in early diagnosis of Alzheimer\u2019s disease. Int J Geriatr Psychiatry 29(7):713\u2013719","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"1500_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jalz.2013.06.009","volume":"10","author":"CY Cheung","year":"2014","unstructured":"Cheung CY, Ong YT, Ikram MK, Ong SY, Li X, Hilal S, Catindig JAS, Venketasubramanian N et al (2014) Microvascular network alterations in the retina of patients with Alzheimer\u2019s disease. Alzheimers Dement 10(2):135\u2013142","journal-title":"Alzheimers Dement"},{"issue":"1\u20134","key":"1500_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000335154","volume":"10","author":"Y Koronyo","year":"2012","unstructured":"Koronyo Y, Salumbides BC, Black KL, Koronyo-Hamaoui M (2012) Alzheimer\u2019s disease in the retina: imaging retinal abeta plaques for early diagnosis and therapy assessment. Neurodegener Dis 10(1\u20134):285\u2013293","journal-title":"Neurodegener Dis"},{"issue":"2","key":"1500_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3233\/JAD-142838","volume":"46","author":"L Velayudhan","year":"2015","unstructured":"Velayudhan L, Gasper A, Pritchard M, Baillon S, Messer C, Proitsi P (2015) Pattern of smell identification impairment in Alzheimer\u2019s disease. J Alzheimers Dis 46(2):381\u2013387","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1500_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189\u2013198","journal-title":"J Psychiatr Res"},{"issue":"4","key":"1500_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0895-4356(97)00060-7","volume":"50","author":"I McDowell","year":"1997","unstructured":"McDowell I, Kristjansson B, Hill GB, H\u00e9bert R (1997) Community screening for dementia: the mini mental state exam (MMSE) and modified mini-mental state exam (3MS) compared. J Clin Epidemiol 50(4):377\u2013383","journal-title":"J Clin Epidemiol"},{"issue":"Pt 1","key":"1500_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/brain\/awn298","volume":"132","author":"EJ Burton","year":"2009","unstructured":"Burton EJ, Barber R, Mukaetova-Ladinska EB, Robson J, Perry RH, Jaros E, Kalaria RN, O\u2019Brien JT (2009) Medial temporal lobe atrophy on MRI differentiates Alzheimer\u2019s disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 132(Pt 1):195\u2013203","journal-title":"Brain"},{"issue":"2","key":"1500_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ki.2013.502","volume":"86","author":"L Cheng","year":"2014","unstructured":"Cheng L, Sun X, Scicluna BJ, Coleman BM, Hill AF (2014) Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. Kidney Int 86(2):433\u2013444","journal-title":"Kidney Int"},{"issue":"1","key":"1500_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jaci.2013.03.006","volume":"132","author":"M Pinkerton","year":"2013","unstructured":"Pinkerton M, Chinchilli V, Banta E, Craig T, August A, Bascom R, Cantorna M, Harvill E et al (2013) Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults. J Allergy Clin Immunol 132(1):217\u2013219","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1500_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030679","volume":"7","author":"A Gallo","year":"2012","unstructured":"Gallo A, Tandon M, Alevizos I, Illei GG (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7(3):e30679","journal-title":"PLoS One"},{"issue":"4","key":"1500_CR22","doi-asserted-by":"publisher","first-page":"8676","DOI":"10.3390\/ijms16048676","volume":"16","author":"B Majem","year":"2015","unstructured":"Majem B, Rigau M, Revent\u00f3s J, Wong D (2015) Non-coding RNAs in saliva: emerging biomarkers for molecular diagnostics. Int J Mol Sci 16(4):8676\u20138698","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1500_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/jamaneurol.2014.3974","volume":"72","author":"AE Monserrate","year":"2015","unstructured":"Monserrate AE, Ryman DC, Ma S, Xiong C, Noble JM, Ringman JM, Morris JC, Danek A et al (2015) Factors associated with the onset and persistence of post-lumbar puncture headache. JAMA Neurol 72(3):325\u2013332","journal-title":"JAMA Neurol"},{"issue":"7","key":"1500_CR24","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1046\/j.1468-2982.2001.00200.x","volume":"21","author":"ST Vilming","year":"2001","unstructured":"Vilming ST, Kloster R, Sandvik L (2001) The importance of sex, age, needle size, height and body mass index in post-lumbar puncture headache. Cephalalgia 21(7):738\u2013743","journal-title":"Cephalalgia"},{"issue":"3","key":"1500_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2174\/156720509788486509","volume":"6","author":"E Peskind","year":"2009","unstructured":"Peskind E, Nordberg A, Darreh-Shori T, Soininen H (2009) Safety of lumbar puncture procedures in patients with Alzheimer\u2019s disease. Curr Alzheimer Res 6(3):290\u2013292","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"1500_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L (2006) Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5(3):228\u2013234","journal-title":"Lancet Neurol"},{"issue":"1","key":"1500_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2003.08.011","volume":"352","author":"H Zetterberg","year":"2003","unstructured":"Zetterberg H, Wahlund LO, Blennow K (2003) Cerebrospinal fluid markers for prediction of Alzheimer\u2019s disease. Neurosci Lett 352(1):67\u201369","journal-title":"Neurosci Lett"},{"issue":"1","key":"1500_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","volume":"69","author":"P Buchhave","year":"2012","unstructured":"Buchhave P et al (2012) Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry 69(1):98\u2013106","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"1500_CR29","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/archneurol.2009.55","volume":"66","author":"BJ Snider","year":"2009","unstructured":"Snider BJ, Fagan AM, Roe C, Shah AR, Grant EA, Xiong C, Morris JC, Holtzman DM (2009) Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer\u2019s type. Arch Neurol 66(5):638\u2013645","journal-title":"Arch Neurol"},{"issue":"2","key":"1500_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1373\/clinchem.2009.130518","volume":"56","author":"C Mulder","year":"2010","unstructured":"Mulder C, Verwey NA, van der Flier WM, Bouwman FH, Kok A, van Elk EJ, Scheltens P, Blankenstein MA (2010) Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin Chem 56(2):248\u2013253","journal-title":"Clin Chem"},{"issue":"4","key":"1500_CR31","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","volume":"7","author":"N Mattsson","year":"2011","unstructured":"Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA et al (2011) The Alzheimer\u2019s Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement 7(4):386\u2013395 e6","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1500_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jalz.2013.01.010","volume":"9","author":"N Mattsson","year":"2013","unstructured":"Mattsson N, Andreasson U, Persson S, Carrillo MC, Collins S, Chalbot S, Cutler N, Dufour-Rainfray D et al (2013) CSF biomarker variability in the Alzheimer\u2019s Association quality control program. Alzheimers Dement 9(3):251\u2013261","journal-title":"Alzheimers Dement"},{"issue":"6","key":"1500_CR33","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jalz.2014.05.1749","volume":"10","author":"A Hye","year":"2014","unstructured":"Hye A, Riddoch-Contreras J, Baird AL, Ashton NJ, Bazenet C, Leung R, Westman E, Simmons A et al (2014) Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement 10(6):799\u2013807 e2","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1500_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/09537104.2012.688899","volume":"24","author":"B Decourt","year":"2013","unstructured":"Decourt B et al (2013) Can platelet BACE1 levels be used as a biomarker for Alzheimer\u2019s disease? Proof-of-concept study. Platelets 24(3):235\u2013238","journal-title":"Platelets"},{"issue":"10","key":"1500_CR35","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","volume":"69","author":"JD Doecke","year":"2012","unstructured":"Doecke JD et al (2012) Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol 69(10):1318\u20131325","journal-title":"Arch Neurol"},{"key":"1500_CR36","doi-asserted-by":"crossref","unstructured":"Ewers, M., et al., CSF biomarkers for the differential diagnosis of Alzheimer\u2019s disease. A large-scale international multicenter study. Alzheimers Dement, 2015.","DOI":"10.1016\/j.jalz.2014.12.006"},{"issue":"8","key":"1500_CR37","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN (2014) Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15(8):509\u2013524","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1500_CR38","doi-asserted-by":"crossref","unstructured":"Kobayashi H, Tomari Y (2015) RISC assembly: coordination between small RNAs and Argonaute proteins. Biochim Biophys Acta","DOI":"10.1016\/j.bbagrm.2015.08.007"},{"key":"1500_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2015.05.001","volume":"87","author":"SM Hammond","year":"2015","unstructured":"Hammond SM (2015) An overview of microRNAs. Adv Drug Deliv Rev 87:3\u201314","journal-title":"Adv Drug Deliv Rev"},{"issue":"16","key":"1500_CR40","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1093\/nar\/gkr254","volume":"39","author":"A Turchinovich","year":"2011","unstructured":"Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39(16):7223\u20137233","journal-title":"Nucleic Acids Res"},{"key":"1500_CR41","doi-asserted-by":"crossref","unstructured":"Leidinger P et al (2013) A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 14(7)","DOI":"10.1186\/gb-2013-14-7-r78"},{"key":"1500_CR42","doi-asserted-by":"crossref","unstructured":"Cheng L et al (2014) Prognostic serum miRNA biomarkers associated with Alzheimer\u2019s disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry","DOI":"10.1038\/mp.2014.127"},{"key":"1500_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fnmol.2014.00002","volume":"7","author":"S Bhatnagar","year":"2014","unstructured":"Bhatnagar S et al (2014) Increased microRNA-34c abundance in Alzheimer\u2019s disease circulating blood plasma. Front Mol Neurosci 7:2","journal-title":"Front Mol Neurosci"},{"issue":"1\u20132","key":"1500_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2013.10.002","volume":"336","author":"L Tan","year":"2014","unstructured":"Tan L, Yu JT, Liu QY, Tan MS, Zhang W, Hu N, Wang YL, Sun L et al (2014) Circulating miR-125b as a biomarker of Alzheimer\u2019s disease. J Neurol Sci 336(1\u20132):52\u201356","journal-title":"J Neurol Sci"},{"issue":"4","key":"1500_CR45","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3233\/JAD-140756","volume":"42","author":"D Galimberti","year":"2014","unstructured":"Galimberti D, Villa C, Fenoglio C, Serpente M, Ghezzi L, Cioffi SMG, Arighi A, Fumagalli G et al (2014) Circulating miRNAs as potential biomarkers in Alzheimer\u2019s disease. J Alzheimers Dis 42(4):1261\u20131267","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"1500_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094839","volume":"9","author":"K Burgos","year":"2014","unstructured":"Burgos K, Malenica I, Metpally R, Courtright A, Rakela B, Beach T, Shill H, Adler C et al (2014) Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer\u2019s and Parkinson\u2019s diseases correlate with disease status and features of pathology. PLoS One 9(5):e94839","journal-title":"PLoS One"},{"issue":"4","key":"1500_CR47","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3233\/JAD-132144","volume":"40","author":"L Tan","year":"2014","unstructured":"Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, Jiang T, Tan L (2014) Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer\u2019s disease. J Alzheimers Dis 40(4):1017\u20131027","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"1500_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069807","volume":"8","author":"P Kumar","year":"2013","unstructured":"Kumar P, Dezso Z, MacKenzie C, Oestreicher J, Agoulnik S, Byrne M, Bernier F, Yanagimachi M et al (2013) Circulating miRNA biomarkers for Alzheimer\u2019s disease. PLoS One 8(7):e69807","journal-title":"PLoS One"},{"issue":"5","key":"1500_CR49","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.3892\/mmr.2014.2484","volume":"10","author":"CG Liu","year":"2014","unstructured":"Liu CG et al (2014) MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer\u2019s disease. Mol Med Rep 10(5):2395\u20132400","journal-title":"Mol Med Rep"},{"issue":"1","key":"1500_CR50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3892\/ijmm.2014.1780","volume":"34","author":"C-G Liu","year":"2014","unstructured":"Liu C-G et al (2014) MicroRNA-384 regulates both amyloid precursor protein and beta-secretase expression and is a potential biomarker for Alzheimer\u2019s disease. Int J Mol Med 34(1):160\u2013166","journal-title":"Int J Mol Med"},{"issue":"2","key":"1500_CR51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/JAD-130932","volume":"39","author":"T Kiko","year":"2014","unstructured":"Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T (2014) MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer\u2019s disease. J Alzheimers Dis 39(2):253\u2013259","journal-title":"J Alzheimers Dis"},{"key":"1500_CR52","first-page":"263","volume":"1","author":"HM Schipper","year":"2007","unstructured":"Schipper HM, Maes OC, Chertkow HM, Wang E (2007) MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Bio 1:263\u2013274","journal-title":"Gene Regul Syst Bio"},{"issue":"5","key":"1500_CR53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3109\/1354750X.2013.814073","volume":"18","author":"LM Bekris","year":"2013","unstructured":"Bekris LM, Lutz F, Montine TJ, Yu CE, Tsuang D, Peskind ER, Leverenz JB (2013) MicroRNA in Alzheimer\u2019s disease: an exploratory study in brain, cerebrospinal fluid and plasma. Biomarkers 18(5):455\u2013466","journal-title":"Biomarkers"},{"issue":"12","key":"1500_CR54","doi-asserted-by":"publisher","first-page":"925","DOI":"10.18632\/aging.100624","volume":"5","author":"KS Sheinerman","year":"2013","unstructured":"Sheinerman KS, Tsivinsky VG, Abdullah L, Crawford F, Umansky SR (2013) Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study. Aging (Albany NY) 5(12):925\u2013938","journal-title":"Aging (Albany NY)"},{"key":"1500_CR55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainres.2014.04.026","volume":"1583","author":"CG Liu","year":"2014","unstructured":"Liu CG, Wang JL, Li L, Xue LX, Zhang YQ, Wang PC (2014) MicroRNA-135a and -200b, potential biomarkers for Alzheimers disease, regulate beta secretase and amyloid precursor protein. Brain Res 1583:55\u201364","journal-title":"Brain Res"},{"issue":"2","key":"1500_CR56","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.expneurol.2011.11.026","volume":"235","author":"H Geekiyanage","year":"2012","unstructured":"Geekiyanage H, Jicha GA, Nelson PT, Chan C (2012) Blood serum miRNA: non-invasive biomarkers for Alzheimer\u2019s disease. Exp Neurol 235(2):491\u2013496","journal-title":"Exp Neurol"},{"key":"1500_CR57","first-page":"625659","volume":"2015","author":"H Dong","year":"2015","unstructured":"Dong H et al (2015) Serum microRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer\u2019s disease. Dis Markers 2015:625659","journal-title":"Dis Markers"},{"issue":"41","key":"1500_CR58","doi-asserted-by":"publisher","first-page":"14820","DOI":"10.1523\/JNEUROSCI.3883-11.2011","volume":"31","author":"H Geekiyanage","year":"2011","unstructured":"Geekiyanage H, Chan C (2011) MicroRNA-137\/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer\u2019s disease. J Neurosci 31(41):14820\u201314830","journal-title":"J Neurosci"},{"issue":"3","key":"1500_CR59","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3892\/etm.2015.2179","volume":"9","author":"Y Zhu","year":"2015","unstructured":"Zhu Y et al (2015) Quantification of microRNA-210 in the cerebrospinal fluid and serum: implications for Alzheimer\u2019s disease. Exp Ther Med 9(3):1013\u20131017","journal-title":"Exp Ther Med"},{"issue":"4","key":"1500_CR60","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/cbf.3184","volume":"34","author":"LH Jia","year":"2016","unstructured":"Jia LH, Liu YN (2016) Downregulated serum miR-223 servers as biomarker in Alzheimer\u2019s disease. Cell Biochem Funct 34(4):233\u2013237","journal-title":"Cell Biochem Funct"},{"issue":"2","key":"1500_CR61","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4088\/JCP.13m08812","volume":"76","author":"T Wang","year":"2015","unstructured":"Wang T, Chen K, Li H, Dong S, Su N, Liu Y, Cheng Y, Dai J et al (2015) The feasibility of utilizing plasma MiRNA107 and BACE1 messenger RNA gene expression for clinical diagnosis of amnestic mild cognitive impairment. J Clin Psychiatry 76(2):135\u2013141","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"1500_CR62","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3233\/JAD-122263","volume":"35","author":"C Villa","year":"2013","unstructured":"Villa C, Ridolfi E, Fenoglio C, Ghezzi L, Vimercati R, Clerici F, Marcone A, Gallone S et al (2013) Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer\u2019s disease. J Alzheimers Dis 35(3):487\u2013494","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1500_CR63","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3233\/JAD-160038","volume":"52","author":"M Muller","year":"2016","unstructured":"Muller M et al (2016) Validation of microRNAs in cerebrospinal fluid as biomarkers for different forms of dementia in a multicenter study. J Alzheimers Dis 52(4):1321\u20131333","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1500_CR64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00401-010-0756-0","volume":"121","author":"WX Wang","year":"2011","unstructured":"Wang WX, Huang Q, Hu Y, Stromberg AJ, Nelson PT (2011) Patterns of microRNA expression in normal and early Alzheimer\u2019s disease human temporal cortex: white matter versus gray matter. Acta Neuropathol 121(2):193\u2013205","journal-title":"Acta Neuropathol"},{"issue":"46","key":"1500_CR65","doi-asserted-by":"publisher","first-page":"31315","DOI":"10.1074\/jbc.M805371200","volume":"283","author":"WJ Lukiw","year":"2008","unstructured":"Lukiw WJ, Zhao Y, Cui JG (2008) An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 283(46):31315\u201331322","journal-title":"J Biol Chem"},{"issue":"5","key":"1500_CR66","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","volume":"28","author":"WX Wang","year":"2008","unstructured":"Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, Nelson PT (2008) The expression of microRNA miR-107 decreases early in Alzheimer\u2019s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28(5):1213\u20131223","journal-title":"J Neurosci"},{"issue":"17","key":"1500_CR67","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1073\/pnas.0710263105","volume":"105","author":"SS Hebert","year":"2008","unstructured":"Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A et al (2008) Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression. Proc Natl Acad Sci U S A 105(17):6415\u20136420","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1500_CR68","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.nbd.2008.11.009","volume":"33","author":"SS Hebert","year":"2009","unstructured":"Hebert SS et al (2009) MicroRNA regulation of Alzheimer\u2019s Amyloid precursor protein expression. Neurobiol Dis 33(3):422\u2013428","journal-title":"Neurobiol Dis"},{"issue":"37","key":"1500_CR69","doi-asserted-by":"publisher","first-page":"14645","DOI":"10.1523\/JNEUROSCI.1327-13.2013","volume":"33","author":"S Absalon","year":"2013","unstructured":"Absalon S, Kochanek DM, Raghavan V, Krichevsky AM (2013) MiR-26b, upregulated in Alzheimer\u2019s disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons. J Neurosci 33(37):14645\u201314659","journal-title":"J Neurosci"},{"issue":"15","key":"1500_CR70","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/hmg\/ddt164","volume":"22","author":"HK Wong","year":"2013","unstructured":"Wong HK et al (2013) De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer\u2019s disease. Hum Mol Genet 22(15):3077\u20133092","journal-title":"Hum Mol Genet"},{"issue":"50","key":"1500_CR71","doi-asserted-by":"publisher","first-page":"38951","DOI":"10.1074\/jbc.M110.178848","volume":"285","author":"JG Cui","year":"2010","unstructured":"Cui JG, Li YY, Zhao Y, Bhattacharjee S, Lukiw WJ (2010) Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J Biol Chem 285(50):38951\u201338960","journal-title":"J Biol Chem"},{"issue":"2","key":"1500_CR72","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neulet.2009.04.052","volume":"459","author":"P Sethi","year":"2009","unstructured":"Sethi P, Lukiw WJ (2009) Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer\u2019s disease temporal lobe neocortex. Neurosci Lett 459(2):100\u2013104","journal-title":"Neurosci Lett"},{"issue":"20","key":"1500_CR73","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1093\/hmg\/ddq311","volume":"19","author":"SS Hebert","year":"2010","unstructured":"Hebert SS et al (2010) Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet 19(20):3959\u20133969","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1500_CR74","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1471-4159.2010.07097.x","volume":"116","author":"P Smith","year":"2011","unstructured":"Smith P, al Hashimi A, Girard J, Delay C, H\u00e9bert SS (2011) In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J Neurochem 116(2):240\u2013247","journal-title":"J Neurochem"},{"issue":"2","key":"1500_CR75","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3233\/JAD-122350","volume":"35","author":"SS Hebert","year":"2013","unstructured":"Hebert SS et al (2013) A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer\u2019s disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. J Alzheimers Dis 35(2):335\u2013348","journal-title":"J Alzheimers Dis"},{"key":"1500_CR76","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainres.2016.05.026","volume":"1646","author":"S Sarkar","year":"2016","unstructured":"Sarkar S, Jun S, Rellick S, Quintana DD, Cavendish JZ, Simpkins JW (2016) Expression of microRNA-34a in Alzheimer\u2019s disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res 1646:139\u2013151","journal-title":"Brain Res"},{"issue":"10","key":"1500_CR77","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/emmm.201201974","volume":"5","author":"P Lau","year":"2013","unstructured":"Lau P, Bossers K, Janky R', Salta E, Frigerio CS, Barbash S, Rothman R, Sierksma ASR et al (2013) Alteration of the microRNA network during the progression of Alzheimer\u2019s disease. EMBO Mol Med 5(10):1613\u20131634","journal-title":"EMBO Mol Med"},{"issue":"1","key":"1500_CR78","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/JAD-2008-14103","volume":"14","author":"JP Cogswell","year":"2008","unstructured":"Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J et al (2008) Identification of miRNA changes in Alzheimer\u2019s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 14(1):27\u201341","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1500_CR79","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/WNR.0b013e3280148e8b","volume":"18","author":"WJ Lukiw","year":"2007","unstructured":"Lukiw WJ (2007) Micro-RNA speciation in fetal, adult and Alzheimer\u2019s disease hippocampus. Neuroreport 18(3):297\u2013300","journal-title":"Neuroreport"},{"issue":"1","key":"1500_CR80","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neurobiolaging.2013.07.005","volume":"35","author":"M Muller","year":"2014","unstructured":"Muller M et al (2014) MicroRNAs in Alzheimer\u2019s disease: differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol Aging 35(1):152\u2013158","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1500_CR81","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/gb-2010-11-5-r56","volume":"11","author":"MA Faghihi","year":"2010","unstructured":"Faghihi MA, Zhang M, Huang J, Modarresi F, van der Brug MP, Nalls MA, Cookson MR, St-Laurent G et al (2010) Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol 11(5):R56","journal-title":"Genome Biol"},{"issue":"4","key":"1500_CR82","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-2990.2010.01076.x","volume":"36","author":"M Shioya","year":"2010","unstructured":"Shioya M, Obayashi S, Tabunoki H, Arima K, Saito Y, Ishida T, Satoh J (2010) Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol Appl Neurobiol 36(4):320\u2013330","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"15","key":"1500_CR83","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.15252\/embj.201387576","volume":"33","author":"J Banzhaf-Strathmann","year":"2014","unstructured":"Banzhaf-Strathmann J, Benito E, May S, Arzberger T, Tahirovic S, Kretzschmar H, Fischer A, Edbauer D (2014) MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer\u2019s disease. EMBO J 33(15):1667\u20131680","journal-title":"EMBO J"},{"issue":"8","key":"1500_CR84","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1074\/jbc.M113.518241","volume":"289","author":"JM Long","year":"2014","unstructured":"Long JM, Ray B, Lahiri DK (2014) MicroRNA-339-5p down-regulates protein expression of beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects. J Biol Chem 289(8):5184\u20135198","journal-title":"J Biol Chem"},{"issue":"37","key":"1500_CR85","doi-asserted-by":"publisher","first-page":"31298","DOI":"10.1074\/jbc.M112.366336","volume":"287","author":"JM Long","year":"2012","unstructured":"Long JM, Ray B, Lahiri DK (2012) MicroRNA-153 physiologically inhibits expression of amyloid-beta precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients. J Biol Chem 287(37):31298\u201331310","journal-title":"J Biol Chem"},{"issue":"2","key":"1500_CR86","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1172\/JCI78421","volume":"125","author":"I Santa-Maria","year":"2015","unstructured":"Santa-Maria I, Alaniz ME, Renwick N, Cela C, Fulga TA, van Vactor D, Tuschl T, Clark LN et al (2015) Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. J Clin Invest 125(2):681\u2013686","journal-title":"J Clin Invest"},{"issue":"2","key":"1500_CR87","first-page":"1565","volume":"8","author":"X Lei","year":"2015","unstructured":"Lei X, Lei L, Zhang Z, Zhang Z, Cheng Y (2015) Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer\u2019s disease. Int J Clin Exp Pathol 8(2):1565\u20131574","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"1500_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008898","volume":"5","author":"J Nunez-Iglesias","year":"2010","unstructured":"Nunez-Iglesias J, Liu CC, Morgan TE, Finch CE, Zhou XJ (2010) Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer\u2019s disease cortex reveals altered miRNA regulation. PLoS One 5(2):e8898","journal-title":"PLoS One"},{"issue":"7","key":"1500_CR89","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.neurobiolaging.2006.05.016","volume":"28","author":"BD Zipser","year":"2007","unstructured":"Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares R, Hulette CM, Vitek MP, Hovanesian V et al (2007) Microvascular injury and blood-brain barrier leakage in Alzheimer\u2019s disease. Neurobiol Aging 28(7):977\u2013986","journal-title":"Neurobiol Aging"},{"key":"1500_CR90","first-page":"140","volume":"9","author":"Q Wu","year":"2016","unstructured":"Wu Q et al (2016) The protective role of microRNA-200c in Alzheimer\u2019s disease pathologies is induced by beta amyloid-triggered endoplasmic reticulum stress. Front Mol Neurosci 9:140","journal-title":"Front Mol Neurosci"},{"issue":"W1","key":"1500_CR91","doi-asserted-by":"publisher","first-page":"W135","DOI":"10.1093\/nar\/gkw288","volume":"44","author":"Y Fan","year":"2016","unstructured":"Fan Y, Siklenka K, Arora SK, Ribeiro P, Kimmins S, Xia J (2016) miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis. Nucleic Acids Res 44(W1):W135\u2013W141","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1500_CR92","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, Khoury JE, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405","journal-title":"Lancet Neurol"},{"issue":"6","key":"1500_CR93","doi-asserted-by":"publisher","first-page":"684","DOI":"10.2174\/138161210790883769","volume":"16","author":"D Bona Di","year":"2010","unstructured":"Di Bona D et al (2010) Immune-inflammatory responses and oxidative stress in Alzheimer\u2019s disease: therapeutic implications. Curr Pharm Des 16(6):684\u2013691","journal-title":"Curr Pharm Des"},{"issue":"10","key":"1500_CR94","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","volume":"73","author":"C Holmes","year":"2009","unstructured":"Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, Culliford D, Perry VH (2009) Systemic inflammation and disease progression in Alzheimer disease. Neurology 73(10):768\u2013774","journal-title":"Neurology"},{"issue":"1","key":"1500_CR95","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12035-012-8234-4","volume":"46","author":"WJ Lukiw","year":"2012","unstructured":"Lukiw WJ, Alexandrov PN (2012) Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer\u2019s disease (AD) brain. Mol Neurobiol 46(1):11\u201319","journal-title":"Mol Neurobiol"},{"issue":"4","key":"1500_CR96","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00401-015-1382-7","volume":"129","author":"LA Leeuwen van","year":"2015","unstructured":"van Leeuwen LA, Hoozemans JJ (2015) Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer\u2019s disease. Acta Neuropathol 129(4):511\u2013525","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1500_CR97","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s12032-011-9823-1","volume":"29","author":"L Feng","year":"2012","unstructured":"Feng L, Xie Y, Zhang H, Wu Y (2012) miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med Oncol 29(2):856\u2013863","journal-title":"Med Oncol"},{"issue":"1","key":"1500_CR98","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neulet.2010.03.054","volume":"476","author":"AI Pogue","year":"2010","unstructured":"Pogue AI, Cui JG, Li YY, Zhao Y, Culicchia F, Lukiw WJ (2010) Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci Lett 476(1):18\u201322","journal-title":"Neurosci Lett"},{"issue":"1","key":"1500_CR99","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/MCB.00589-15","volume":"36","author":"PK Modi","year":"2016","unstructured":"Modi PK, Jaiswal S, Sharma P (2016) Regulation of neuronal cell cycle and apoptosis by microRNA 34a. Mol Cell Biol 36(1):84\u201394","journal-title":"Mol Cell Biol"},{"issue":"5648","key":"1500_CR100","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1126\/science.1090154","volume":"302","author":"Y Zhou","year":"2003","unstructured":"Zhou Y, Su Y, Li B, Liu F, Ryder JW, Wu X, Gonzalez-DeWhitt P, Gelfanova V et al (2003) Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science 302(5648):1215\u20131217","journal-title":"Science"},{"issue":"Pt 2","key":"1500_CR101","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1242\/jcs.03323","volume":"120","author":"A Mendoza-Naranjo","year":"2007","unstructured":"Mendoza-Naranjo A, Gonzalez-Billault C, Maccioni RB (2007) Abeta1-42 stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTPases. J Cell Sci 120(Pt 2):279\u2013288","journal-title":"J Cell Sci"},{"issue":"1","key":"1500_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029722","volume":"7","author":"S Yamamura","year":"2012","unstructured":"Yamamura S, Saini S, Majid S, Hirata H, Ueno K, Deng G, Dahiya R (2012) MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells. PLoS One 7(1):e29722","journal-title":"PLoS One"},{"issue":"1","key":"1500_CR103","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3233\/JAD-2010-1203","volume":"19","author":"G Huesa","year":"2010","unstructured":"Huesa G, Baltrons MA, G\u00f3mez-Ramos P, Mor\u00e1n A, Garc\u00eda A, Hidalgo J, Franc\u00e9s S, Santpere G et al (2010) Altered distribution of RhoA in Alzheimer\u2019s disease and AbetaPP overexpressing mice. J Alzheimers Dis 19(1):37\u201356","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1500_CR104","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jnr.22290","volume":"88","author":"MG Tan","year":"2010","unstructured":"Tan MG, Chua WT, Esiri MM, Smith AD, Vinters HV, Lai MK (2010) Genome wide profiling of altered gene expression in the neocortex of Alzheimer\u2019s disease. J Neurosci Res 88(6):1157\u20131169","journal-title":"J Neurosci Res"},{"issue":"2","key":"1500_CR105","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neurobiolaging.2014.09.027","volume":"36","author":"S Sekar","year":"2015","unstructured":"Sekar S, McDonald J, Cuyugan L, Aldrich J, Kurdoglu A, Adkins J, Serrano G, Beach TG et al (2015) Alzheimer\u2019s disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes. Neurobiol Aging 36(2):583\u2013591","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1500_CR106","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/jnr.10351","volume":"70","author":"V Colangelo","year":"2002","unstructured":"Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70(3):462\u2013473","journal-title":"J Neurosci Res"},{"issue":"10","key":"1500_CR107","first-page":"136","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang WY et al (2015) Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med 3(10):136","journal-title":"Ann Transl Med"},{"issue":"3","key":"1500_CR108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090770","volume":"9","author":"JJ Li","year":"2014","unstructured":"Li JJ, Dolios G, Wang R, Liao FF (2014) Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression. PLoS One 9(3):e90770","journal-title":"PLoS One"},{"issue":"5","key":"1500_CR109","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.3892\/mmr.2015.4265","volume":"12","author":"G Jiao","year":"2015","unstructured":"Jiao G et al (2015) MicroRNA-21 regulates cell proliferation and apoptosis in H(2)O(2)-stimulated rat spinal cord neurons. Mol Med Rep 12(5):7011\u20137016","journal-title":"Mol Med Rep"},{"issue":"9","key":"1500_CR110","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.1523\/JNEUROSCI.15-09-06213.1995","volume":"15","author":"SA Scott","year":"1995","unstructured":"Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA (1995) Nerve growth factor in Alzheimer\u2019s disease: increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 15(9):6213\u20136221","journal-title":"J Neurosci"},{"issue":"11","key":"1500_CR111","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","volume":"8","author":"EJ Mufson","year":"2008","unstructured":"Mufson EJ, Counts SE, Perez SE, Ginsberg SD (2008) Cholinergic system during the progression of Alzheimer\u2019s disease: therapeutic implications. Expert Rev Neurother 8(11):1703\u20131718","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"1500_CR112","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/(SICI)1096-9861(19990906)411:4<693::AID-CNE13>3.0.CO;2-D","volume":"411","author":"ML Gilmor","year":"1999","unstructured":"Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, Mufson EJ, Levey AI (1999) Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer\u2019s disease. J Comp Neurol 411(4):693\u2013704","journal-title":"J Comp Neurol"},{"issue":"8","key":"1500_CR113","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.neuint.2012.03.010","volume":"60","author":"N Hamada","year":"2012","unstructured":"Hamada N, Fujita Y, Kojima T, Kitamoto A, Akao Y, Nozawa Y, Ito M (2012) MicroRNA expression profiling of NGF-treated PC12 cells revealed a critical role for miR-221 in neuronal differentiation. Neurochem Int 60(8):743\u2013750","journal-title":"Neurochem Int"},{"issue":"2","key":"1500_CR114","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.mp.4001208","volume":"8","author":"GV Ferrari De","year":"2003","unstructured":"De Ferrari GV et al (2003) Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol Psychiatry 8(2):195\u2013208","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1500_CR115","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.yexcr.2004.02.028","volume":"297","author":"AR Alvarez","year":"2004","unstructured":"Alvarez AR, Godoy JA, Mullendorff K, Olivares GH, Bronfman M, Inestrosa NC (2004) Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Exp Cell Res 297(1):186\u2013196","journal-title":"Exp Cell Res"},{"issue":"27","key":"1500_CR116","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007245","volume":"96","author":"ZC Zhang","year":"2017","unstructured":"Zhang ZC, Liu JX, Shao ZW, Pu FF, Wang BC, Wu Q, Zhang YK, Zeng XL et al (2017) In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt\/beta-catenin signaling pathway in osteosarcoma. Medicine (Baltimore) 96(27):e7245","journal-title":"Medicine (Baltimore)"},{"key":"1500_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.437","volume":"4","author":"N He","year":"2013","unstructured":"He N, Jin WL, Lok KH, Wang Y, Yin M, Wang ZJ (2013) Amyloid-beta(1-42) oligomer accelerates senescence in adult hippocampal neural stem\/progenitor cells via formylpeptide receptor 2. Cell Death Dis 4:e924","journal-title":"Cell Death Dis"},{"issue":"9","key":"1500_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045069","volume":"7","author":"R Bhat","year":"2012","unstructured":"Bhat R, Crowe EP, Bitto A, Moh M, Katsetos CD, Garcia FU, Johnson FB, Trojanowski JQ et al (2012) Astrocyte senescence as a component of Alzheimer\u2019s disease. PLoS One 7(9):e45069","journal-title":"PLoS One"},{"issue":"7","key":"1500_CR119","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1101\/gad.1767609","volume":"23","author":"MT Le","year":"2009","unstructured":"Le MT et al (2009) MicroRNA-125b is a novel negative regulator of p53. Genes Dev 23(7):862\u2013876","journal-title":"Genes Dev"},{"key":"1500_CR120","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1038\/onc.2012.640","volume":"32","author":"A Rufini","year":"2013","unstructured":"Rufini A, Tucci P, Celardo I, Melino G (2013) Senescence and aging: the critical roles of p53. Oncogene 32:5129\u20135143","journal-title":"Oncogene"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1500-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-1500-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1500-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T13:00:25Z","timestamp":1720962025000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-1500-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,8]]},"references-count":120,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1500"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-1500-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,8]]},"assertion":[{"value":"12 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}